Griseofulvin
- Strength
- 125 mg/5mL
- Form
- Suspension
- Class
- Tubulin Inhibiting Agent
Cosette Pharmaceuticals, Inc.
Listed by Sigmapharm Laboratories, LLC
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Tubulin Inhibiting Agent |
| Approval route | ANDA — approved generic |
| NDC code | 42794-012 |
| FDA application | ANDA202482 |
| RxNorm concept | 310600 |
| Package sizes listed | 1 |
| Marketed since | December 2012 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Cosette Pharmaceuticals, Inc.
Sandoz Inc
Sandoz Inc
Griseofulvin (microsize)
Chartwell RX, LLC.
Actavis Pharma, Inc.
griseofulvin
Chartwell RX, LLC.
griseofulvin
Heritage Pharmaceuticals Inc d/b/a Avet Pharmac…
Cipla USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.